Physician profile
Christodoulos Kaoutzanis
NPI 1043521065
$120,039.89
in general payments reported to CMS, 2019-2025
33 companies · $79K in 2025
The $79K reported for 2025 was more than what 99% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,850 · 2020: $1,670 · 2021: $2,938 · 2022: $4,588 · 2023: $8,687 · 2024: $20K · 2025: $79K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $33K · Honoraria: $32K · Food and Beverage: $30K · Travel and Lodging: $11K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,095 · Gift: $87.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $33,368.69 |
| Honoraria | $32,400.00 |
| Food and Beverage | $30,076.07 |
| Travel and Lodging | $10,966.78 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,095.00 |
| Gift | $87.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $49,736.89 | 2020-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Davol INC. | $33,575.63 | 2022-2025 | Arista, Phasix Mesh, Surgiphor |
| Rti Surgical, INC | $8,113.39 | 2023-2025 | |
| Motiva USA, LLC | $4,865.68 | 2024-2025 | |
| Bone Support INC. | $3,579.11 | 2024-2025 | Cerament G, Ceramentbone Void Filler |
| Musculoskeletal Transplant Foundation INC. | $3,198.94 | 2022-2025 | |
| Mentor Worldwide LLC | $2,751.28 | 2022-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Axogen | $2,705.87 | 2019-2025 | Avance Nerve Graft, Axoguard Nerve Protector, Axoguard Ha+ Nerve Protector |
| Sientra, INC. | $1,985.52 | 2020-2022 | |
| Allergan, INC. | $1,400.72 | 2019-2022 | |
| Abbvie INC. | $1,368.25 | 2023-2025 | |
| Becton, Dickinson and Company | $1,263.65 | 2024-2025 | Phasix Mesh |
| Integra Lifesciences Corporation | $1,123.61 | 2022-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Ethicon US, LLC | $714.10 | 2022-2024 | Monocryl, Surgicel Nu-Knit |
| Depuy Synthes Sales INC. | $586.42 | 2020-2025 | Matrixmidface, Na, Trumatch |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kls-Martin L.P. | $574.34 | 2024 | |
| Avita Medical Americas, LLC | $357.35 | 2023-2025 | Recell, Cohealyx, Permeaderm |
| Kerecis Limited | $281.15 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Bard Peripheral Vascular, INC. | $263.37 | 2021 | |
| Polynovo North America LLC | $178.65 | 2023 | |
| Access Pro Medical, LLC | $171.75 | 2025 | Matriderm |
| Aroa Biosurgery Incorporated | $145.69 | 2023-2025 | |
| Acell, INC. | $145.66 | 2019 | |
| Innovation Technologies INC | $138.27 | 2022 | |
| Next Science LLC | $137.13 | 2025 | Blastx, Xperience |
| Acera Surgical, INC. | $128.24 | 2023 | Restrata Wound Matrix |
| Vertex Pharmaceuticals Incorporated | $125.00 | 2025 | |
| Smith+Nephew, INC. | $116.59 | 2023 | |
| Convatec INC. | $114.12 | 2023 | |
| Solta Medical, A Division of Bausch Health US, LLC | $95.60 | 2025 | |
| Medtronic, INC. | $50.00 | 2021 | |
| W. L. Gore & Associates, INC. | $35.35 | 2024 | Gore Enform Preperitoneal Biomaterial |
| Baxter Healthcare | $12.57 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christodoulos Kaoutzanis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.